Treatable traits: a comprehensive precision medicine approach in interstitial lung disease, but why were acute exacerbations not considered?
Eur Respir J
.
2023 Sep 21;62(3):2301449.
doi: 10.1183/13993003.01449-2023.
Print 2023 Sep.
Authors
Onofre Moran-Mendoza
1
2
,
Maria A Coppola-Lamas
3
2
,
Elham Alrubai
3
2
,
Carla Paredes
2
Affiliations
1
Division of Respirology and Sleep Medicine, Queen's University, Kingston, ON, Canada morano@queensu.ca.
2
Kingston Health Sciences Center, Kingston, ON, Canada.
3
Division of Respirology and Sleep Medicine, Queen's University, Kingston, ON, Canada.
PMID:
37734844
DOI:
10.1183/13993003.01449-2023
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Lung Diseases, Interstitial* / genetics
Lung Diseases, Interstitial* / therapy
Precision Medicine*